News Biocon Limited

Equities

BIOCON

INE376G01013

Delayed NSE India S.E. Other stock markets 06:29:21 2024-06-03 am EDT			5-day change	1st Jan Change
309.6 ^INR	+0.13%		-1.68%	+24.03%

May. 24	INDIA STOCKS-Indian shares surrender gains as U.S. rate worries weigh	RE
May. 24	Biocon Ties Up with Handok to Market Anti-Diabetic Drug Liraglutide in South Korea	MT

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

INDIA STOCKS-Indian shares surrender gains as U.S. rate worries weigh	May. 24	RE
Biocon Ties Up with Handok to Market Anti-Diabetic Drug Liraglutide in South Korea	May. 24	MT
Biocon Limited Signs Exclusive Licensing and Supply Deal for the Commercialization of Liraglutide in South Korea with Handok Inc	May. 23	CI
US FDA Approves Samsung Bioepis' Eye Disease Drug Opuviz	May. 23	MT
Jefferies Adjusts Biocon’s Price Target to INR230 From INR250, Keeps at Underperform	May. 17	MT
Biocon's Consolidated Net Profit Declines in Fiscal Q4	May. 17	MT
India's Biocon posts Q4 profit fall as higher raw material costs bite	May. 16	RE
Transcript : Biocon Limited, Q4 2024 Earnings Call, May 16, 2024	May. 16
Biocon Limited Proposes Final Dividend for the Financial Year Ended March 31, 2024, Payable on or Before September 6, 2024	May. 16	CI
Biocon Limited Reports Earnings Results for the Full Year Ended March 31, 2024	May. 16	CI
Biocon Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	May. 16	CI
Biocon Limited signs semi-exclusive distribution and supply deal for the commercialization of generic Saxenda in Mexico with Medix	May. 13	AQ
Biocon Signs Deal with Medix for Commercialization of Chronic Weight Management Drug in Mexico	May. 13	MT
Biocon Limited Signs Semi-Exclusive Distribution and Supply Deal for the Commercialization of Generic Saxenda® (Liraglutide) in Mexico with Medix	May. 12	CI
Biocon Limited Receives Demand Orders from Assistant Commissioner of State Tax Guwahati, Assam and Sales Tax Officer Class II/Avato, Ward 41, Zone 3, Delhi	May. 01	CI
Biocon Limited Receives Demand Orders from the Office of Deputy State Tax Officer-1, Purasawakkam Assessment Circle, Chennai and Assistant Commissioner, Commercial Taxes Department, Visakhapatnam II Division	Apr. 30	CI
Natural Biocon (India) CFO Passes Away	Apr. 30	MT
Biocon Limited Receives Approval from the South African Health Products Regulatory Authority for its Vertically Integrated, Complex Drug Product Tacrolimus Capsule 0.5mg, 1mg and 5mg Strengths, in South Africa	Apr. 20	CI
India's Biocon developing its own version of Wegovy, clinical trial likely next year	Apr. 18	RE
Biocon Signs Licensing and Supply Pact with Biomm to Commercialize Generic Ozempic in Brazil	Apr. 17	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Biocon Limited

Equities

BIOCON

INE376G01013

Summary

Filters